e-learning
resources
Virtual 2021
05.09.2021
Biomarkers and e-health in idiopathic interstitial pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Autoantibodies in Interstitial Lung Diseases
A. Bostanoglu (Ankara, Turkey), G. Celik (Ankara, Turkey)
Source:
Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Session:
Biomarkers and e-health in idiopathic interstitial pneumonia
Session type:
E-poster
Number:
394
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Bostanoglu (Ankara, Turkey), G. Celik (Ankara, Turkey). Autoantibodies in Interstitial Lung Diseases. 394
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic.
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Multicenter Registry of Interstitial Lung Diseases in Brazil
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
Gender perspective in Interstitial Lung Diseases (ILD)
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019
Telomere length in fibrotic groups of Interstitial Lung Diseases
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018
Case Series of COVID-19 Disease in Pediatric Chronic Lung Diseases
Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function
Year: 2021
Evaluation of three dyspnea questionnaires in the progression of Interstitial Lung Diseases.
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
Assessment of Treatment Response in Granulomatous Lymphocytic Interstitial Lung Disease (GLILD)
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019
A Comparison of Pulmonary Rehabilitation Outcomes in Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019
Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
Characteristics of Connective Tissue Diseases Associated Interstitial Lung Diseases - A Single Centre Study in Sri Lanka
Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends
Year: 2021
Utility of Lung Ultrasound in Interstitial Lung Disease - A Paradigm Shift
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020
Lung Volume Reduction Surgery for Emphysema
Source: Eur Respir J 2004; 24 : 713
Year: 2004
Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017
Impact of a Bayesian approach on the diagnosis of Interstitial Lung Diseases
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019
Resistance Training Alone Improves Lung Inflammation and Respiratory Muscle Strenght but not Lung Function and Mechanics in Mid-Age Women
Source: Virtual Congress 2020 – Novel insights into exercise training
Year: 2020
Combined pulmonary fibrosis and emphysema: A report from the Hellenic Interstitial Lung Diseases group
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010
Lung Micobiome in Lung Cancer
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020
DANILDA – The First Danish National Interstitial Lung Disease Registry
Source: International Congress 2019 – Interstitial lung disease registries
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept